Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. WELL Health Technologies's accounts receivables for the quarter that ended in Mar. 2026 was $132 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
WELL Health Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 44.76.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. WELL Health Technologies's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was $-2.93.
WELL Health Technologies Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
WELL Health Technologies's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), WELL Health Technologies's accounts receivable are only considered to be worth 75% of book value:
WELL Health Technologies's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
WELL Health Technologies Accounts Receivable Related Terms
WELL Health Technologies Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WELL Health Technologies Accounts Receivable Chart
WELL Health Technologies (WHTCF) has a Accounts Receivable of $132 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on WELL Health Technologies and its competitors.
Is WELL Health Technologies' Accounts Receivable too high?
WELL Health Technologies' current Accounts Receivable is $132 Mil. Overall, WELL Health Technologies has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does WELL Health Technologies' Accounts Receivable compare to HCA and THC?
WELL Health Technologies' Accounts Receivable of $132 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on WELL Health Technologies and its competitors. WELL Health Technologies's current Accounts Receivable is $132 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is WELL Health Technologies stock overvalued right now?
Based on GuruFocus' analysis, WELL Health Technologies (WHTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $5.17, compared to a current price of $2.89 — trading 44.1% below its estimated fair value. The current Accounts Receivable is $132 Mil. WELL Health Technologies' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For WELL Health Technologies (WHTCF), the current Accounts Receivable is $132 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is WELL Health Technologies (WHTCF) Overvalued in 2026?
Based on GuruFocus' analysis, WELL Health Technologies stock appears to be undervalued.
The current stock price of $2.89 is trading 44.1% below its estimated GF Value™ of $5.17.
GuruFocus considers WELL Health Technologies to be Possible Value Trap.
Key valuation signals for WHTCF:
Accounts Receivable: $132 Mil
GF Value™: $5.17 vs. price of $2.89 (44.1% below fair value)
No single metric tells the full story. See the WHTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
WELL Health Technologies Corp is a practitioner-focused digital healthcare company. It has seven reportable segments that are grouped into three key business units: Canadian Patient Services that includes Primary and Specialized MyHealth; WELL Health USA Patient Services, which derives maximum revenue, includes Primary Circle Medica, Primary WISP, Specialized CRH Medical, and Specialized Provider Staffing; SaaS and Technology Services provides digital health and infrastructure solutions for healthcare providers, including Electronic MedicalRecords (EMRs), patient engagement and eReferral solutions, AI-enabled applications, billing and practice management services, and cybersecurity protection and data privacy solutions; and HEALWELL: AI and data sciences and healthcare software offerings.
76GF Score
Get the complete analysis for WHTCF
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WHTCF has been successfully added to your 
